86
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Longer distance to specialized treatment centers does not adversely affect treatment intensity or outcomes in adult acute myeloid leukemia patients. A Danish national population-based cohort study

, , , , , , , & show all
Pages 769-780 | Published online: 28 Aug 2019

References

  • Döhner H, Estey E, Grimwade D, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood. 2017;129(4):424–447. doi:10.1182/blood-2016-08-73319627895058
  • Østgård LS, Nørgaard JM, Severinsen M, et al. Data quality in the Danish National Acute Leukemia Registry: a hematological data resource. Clin Epidemiol. 2013;5:335–344. doi:10.2147/CLEP.S4841124039451
  • Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues WHO Classification of Tumours. Vol. 2, Revised 4th ed. IARC WHO Classification of Tumours;2017. Lyon, France.
  • Granfeldt Ostgard LS, Medeiros BC, Sengelov H, et al. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study. J Clin Oncol. 2015;33(31):3641–3649. doi:10.1200/JCO.2014.60.089026304885
  • Ostgard LS, Norgaard JM, Sengelov H, et al. Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study. Leukemia. 2015;29(3):548–555. doi:10.1038/leu.2014.23425092141
  • Hahn AW, Jamy O, Nunnery S, et al. How center volumes affect early outcomes in acute myeloid leukemia. Clin Lymphoma Myeloma Leuk. 2015;15(11):646–654. doi:10.1016/j.clml.2015.07.64626386907
  • Giri S, Pathak R, Aryal MR, Karmacharya P, Bhatt VR, Martin MG. Impact of hospital volume on outcomes of patients undergoing chemotherapy for acute myeloid leukemia: a matched cohort study. Blood. 2015;125(21):3359–3360. doi:10.1182/blood-2015-01-62576425999448
  • Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol. 2000;18(11):2327–2340. doi:10.1200/JCO.2000.18.11.232710829054
  • [Sundhedsstyrelsen] TDHA. Gældende specialeplan for hæmatologi Maj. 2019 Available from: https://www.sst.dk/da/Viden/Specialeplanlaegning/Gaeldende-specialeplan/Specialeplan-for-intern-medicin-haematologi. Accessed 731, 2019.
  • Ostgard LS, Norgaard JM, Raaschou-Jensen KK, et al. The Danish National Acute Leukemia Registry. Clin Epidemiol. 2016;8:553–560. doi:10.2147/CLEP.S9946027822099
  • Kelly C, Hulme C, Farragher T, Clarke G. Are differences in travel time or distance to healthcare for adults in global north countries associated with an impact on health outcomes? A systematic review. BMJ Open. 2016;6(11):e013059. doi:10.1136/bmjopen-2016-013059
  • Rodriguez CP, Baz R, Jawde RA, et al. Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia. Leuk Res. 2008;32(3):413–420. doi:10.1016/j.leukres.2007.07.01517727945
  • Master S, Munker R, Shi Z, Mills G, Shi R. Insurance status and other non-biological factors predict outcomes in acute myelogenous leukemia: analysis of data from the national cancer database. Anticancer Res. 2016;36(9):4915–4921. doi:10.21873/anticanres.1105727630349
  • Danish Regions. https://www.regioner.dk/services/in-english. Accessed 924, 2018.
  • Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • The Danish Society of Hematology. [Recommandations for blood and bonemarrow transplatation]. 2017 [ updated 2017]. Available from: http://www.hematology.dk/index.php/vejledninger/knoglemarvstransplantation.0. Accessed 731, 2019.
  • The Danish National Acute Leukemia Group. Annual Report [Årsrapport]. Denmark: The Danish National Acute Leukemia Group; 2017.
  • The Danish National Acute Leukemia Group; Denmark. The Danish Society of Hematology. [Recomandations for Treatment, Diagnostics, and Management of Acute Myeloid Leukemia (AML)]; 2019.
  • Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health. 2011;39(7 Suppl):103–105. doi:10.1177/140349481140509821775365
  • Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7 Suppl):91–94. doi:10.1177/140349481039471521775362
  • Petersson F, Baadsgaard M, Thygesen LC. Danish registers on personal labour market affiliation. Scand J Public Health. 2011;39(7 Suppl):95–98. doi:10.1177/140349481140848321775363
  • Sortso C, Thygesen LC, Bronnum-Hansen H. Database on Danish population-based registers for public health and welfare research. Scand J Public Health. 2011;39(7 Suppl):17–19. doi:10.1177/1403494811399171
  • Statistics Denmark. 2017 http://www.dst.dk/en. Accessed 731, 2019.
  • Ostgard LSG, Norgaard M, Medeiros BC, et al. Associations between cohabitation status, treatment, and outcome in AML patients: a national population-based study. Blood. 2018;131(24):2730–2733. doi:10.1182/blood-2017-11-81432729695517
  • Ostgard LSG, Norgaard M, Medeiros BC, et al. Effects of education and income on treatment and outcome in patients with acute myeloid leukemia in a tax-supported health care system: a national population-based cohort study. J Clin Oncol. 2017;35:3678–3687. doi:10.1200/JCO.2017.73.672828892433
  • Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354–365. doi:10.1182/blood-2009-11-25444120385793
  • Cheson BD, Bennett JM, Kopecky KJ, et al. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21(24):4642–4649. doi:10.1200/JCO.2003.04.03614673054
  • Lowenberg B, Pabst T, Vellenga E, et al. Cytarabine dose for acute myeloid leukemia. N Engl J Med. 2011;364(11):1027–1036. doi:10.1056/NEJMoa101022221410371
  • Oken M, Creech R, Tormey D, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–655.
  • Rising B. Multiple Imputation. Bologna (Italy): StataCorp LP; 2010.
  • Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009 Jun 29;338:b2393. doi: 10.1136/bmj.b2393.
  • White IR, Royston P. Imputing missing covariate values for the Cox model. Stat Med. 2009;28(15):1982–1998. doi:10.1002/sim.361819452569
  • Jun Zhang MB, PhD KF, Yu P. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1691. doi:10.1001/jama.280.19.16909832001
  • Abou-Nassar KE, Kim HT, Blossom J, et al. The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(5):708–715. doi:10.1016/j.bbmt.2011.08.02221906576
  • Bhatt VR, Shostrom V, Giri S, et al. Early mortality and overall survival of acute myeloid leukemia based on facility type. Am J Hematol. 2017;92(8):764–771. doi:10.1002/ajh.2476728437868
  • Khera N, Gooley T, Flowers MED, et al. Association of distance from transplantation center and place of residence on outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(7):1319–1323. doi:10.1016/j.bbmt.2016.03.01927013013